Published in Nat Rev Nephrol on February 01, 2010
Strict blood-pressure control and progression of renal failure in children. N Engl J Med (2009) 5.71
Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int (2006) 3.48
Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension (2008) 2.84
Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension (2008) 2.24
Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol (2009) 1.80
ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group. Kidney Int (2000) 1.37
Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol (2002) 0.94
Blood-pressure control and delay in progression of kidney disease in children. N Engl J Med (2009) 0.90
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
New equations to estimate GFR in children with CKD. J Am Soc Nephrol (2009) 11.48
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood (2011) 5.98
Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy. Blood (2014) 2.94
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension (2010) 2.47
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS). Circulation (2008) 2.41
Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex (2005) 2.37
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. Hypertension (2007) 2.37
The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34
Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol (2007) 2.25
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis (2011) 2.11
Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol (2003) 2.08
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation (2011) 1.97
Age-related changes in brain activation during a delayed item recognition task. Neurobiol Aging (2006) 1.87
Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol (2009) 1.80
A common neural network for cognitive reserve in verbal and object working memory in young but not old. Cereb Cortex (2007) 1.71
Is it time for a cardiovascular primary prevention trial in the elderly? Stroke (2006) 1.69
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Cognitive reserve modulates functional brain responses during memory tasks: a PET study in healthy young and elderly subjects. Neuroimage (2003) 1.62
Modulation of melanocortin signaling ameliorates uremic cachexia. Kidney Int (2008) 1.60
Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease. Am J Physiol Renal Physiol (2012) 1.58
Adolescent and young adult oncology. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2012) 1.55
Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. J Ren Nutr (2013) 1.53
Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. J Clin Hypertens (Greenwich) (2005) 1.51
Identification of endoplasmic reticulum stress-inducing agents by antagonizing autophagy: a new potential strategy for identification of anti-cancer therapeutics in B-cell malignancies. Leuk Lymphoma (2013) 1.50
Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens (2005) 1.49
Predictors of blood pressure and its control in pediatric patients receiving dialysis. J Pediatr (2011) 1.46
Positive evidence against human hippocampal involvement in working memory maintenance of familiar stimuli. Cereb Cortex (2004) 1.45
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle (2011) 1.39
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am J Kidney Dis (2008) 1.38
Association between hyperuricemia and incident heart failure among older adults: a propensity-matched study. Int J Cardiol (2009) 1.38
Structural MRI covariance patterns associated with normal aging and neuropsychological functioning. Neurobiol Aging (2006) 1.37
Potentiation of high-LET radiation by gemcitabine: targeting HER2 with trastuzumab to treat disseminated peritoneal disease. Clin Cancer Res (2007) 1.34
Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.34
Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest (2005) 1.30
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood (2009) 1.25
Exploring the neural basis of cognitive reserve. J Clin Exp Neuropsychol (2003) 1.23
Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol (2010) 1.20
Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy. Arch Intern Med (2009) 1.19
Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol (2011) 1.18
Relation of cognitive reserve and task performance to expression of regional covariance networks in an event-related fMRI study of nonverbal memory. Neuroimage (2003) 1.18
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.18
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.16
Pheochromocytoma in pregnancy: a case series and review. Hypertension (2010) 1.14
Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease. Clin Cancer Res (2008) 1.14
Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate. Cancer Genet (2011) 1.06
International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension. J Am Coll Cardiol (2013) 1.05
Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease. Arch Neurol (2004) 1.05
Identification and differential vulnerability of a neural network in sleep deprivation. Cereb Cortex (2004) 1.04
A propensity-matched study of hypertension and increased stroke-related hospitalization in chronic heart failure. Am J Cardiol (2008) 1.02
Peripheral administration of the melanocortin-4 receptor antagonist NBI-12i ameliorates uremia-associated cachexia in mice. J Am Soc Nephrol (2007) 1.02
Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study. Int J Cardiol (2009) 1.02
Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study. Int J Cardiol (2009) 1.01
Efficacy and safety of canagliflozin in patients with type 2 diabetes and stage 3 nephropathy. Am J Nephrol (2014) 1.01
Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window. Pediatr Nephrol (2010) 1.00
A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure. Int J Cardiol (2008) 0.99
Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation. Br J Haematol (2010) 0.99
Adolescent and young adult oncology, version 2.2014. J Natl Compr Canc Netw (2014) 0.98
Pathogenesis and clinical physiology of hypertension. Cardiol Clin (2010) 0.97
Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation (2014) 0.96
Protein energy wasting in children with chronic kidney disease. Pediatr Nephrol (2014) 0.95
Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich) (2010) 0.94
The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol (2013) 0.92
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease. J Am Soc Nephrol (2010) 0.92
Using an established telehealth model to train urban primary care providers on hypertension management. J Clin Hypertens (Greenwich) (2011) 0.92
Nutrition and growth in children with chronic kidney disease. Nat Rev Nephrol (2011) 0.92
Pathogenesis and treatment of microalbuminuria in patients with diabetes: the road ahead. J Clin Hypertens (Greenwich) (2009) 0.92
BP control and left ventricular hypertrophy regression in children with CKD. J Am Soc Nephrol (2013) 0.92
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know? J Clin Hypertens (Greenwich) (2010) 0.88
Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective. J Hypertens (2012) 0.88
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma. Am J Hematol (2013) 0.87
Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele). Am J Geriatr Psychiatry (2004) 0.87
Acute kidney injury in children: the dawn of a new era. Pediatr Nephrol (2008) 0.87
Association of race and body mass index with ESRD and mortality in CKD stages 3-4: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2012) 0.86
Single-pill combination of telmisartan/amlodipine versus amlodipine monotherapy in diabetic hypertensive patients: an 8-week randomized, parallel-group, double-blind trial. Clin Ther (2012) 0.86
Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension - Insights From the SYMPLICITY HTN-3 Trial. Circ J (2016) 0.85
A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice. J Am Soc Nephrol (2013) 0.85
Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study. Pediatr Nephrol (2014) 0.84
Ghrelin and its analogues as therapeutic agents for anorexia and cachexia in end-stage renal disease. Kidney Int (2009) 0.84
Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol (2011) 0.84
Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr (2014) 0.83
Treatment of obesity-related hypertension in children and adolescents. Curr Hypertens Rep (2013) 0.83
Status of Diabetes Care: New Challenges, New Concepts, New Measures--Focusing on the Future! Diabetes Care (2015) 0.82
Should nephrologists use beta-blockers? A perspective. Nephrol Dial Transplant (2008) 0.82
Ghrelin in chronic kidney disease. Int J Pept (2010) 0.81
Treatment and control of high blood pressure in adults. Cardiol Clin (2010) 0.81
Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy. Clin J Am Soc Nephrol (2013) 0.81
Distinct spatial patterns of brain activity associated with memory storage and search. Neuroimage (2006) 0.81
Ghrelin and leptin pathophysiology in chronic kidney disease. Pediatr Nephrol (2012) 0.81
Status of Diabetes Care: "It just doesn't get any better . . . or does it?". Diabetes Care (2014) 0.81
Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol (2012) 0.80